BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30705887)

  • 1. Macrophage Lysophosphatidylcholine Acyltransferase 3 Deficiency-Mediated Inflammation Is Not Sufficient to Induce Atherosclerosis in a Mouse Model.
    Jiang H; Li Z; Huan C; Jiang XC
    Front Cardiovasc Med; 2018; 5():192. PubMed ID: 30705887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency in lysophosphatidylcholine acyltransferase 3 reduces plasma levels of lipids by reducing lipid absorption in mice.
    Li Z; Jiang H; Ding T; Lou C; Bui HH; Kuo MS; Jiang XC
    Gastroenterology; 2015 Nov; 149(6):1519-29. PubMed ID: 26226572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidylcholine acyltransferase 3 deficiency impairs 3T3L1 cell adipogenesis through activating Wnt/β-catenin pathway.
    Feng C; Lou B; Dong J; Li Z; Chen Y; Li Y; Zhang X; Jiang XC; Ding T
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):834-843. PubMed ID: 29673706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LPCAT3 deficiency in hematopoietic cells alters cholesterol and phospholipid homeostasis and promotes atherosclerosis.
    Thomas C; Jalil A; Magnani C; Ishibashi M; Queré R; Bourgeois T; Bergas V; Ménégaut L; Patoli D; Le Guern N; Labbé J; Gautier T; de Barros JPP; Lagrost L; Masson D
    Atherosclerosis; 2018 Aug; 275():409-418. PubMed ID: 29866392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of lysophosphatidylcholine acyltransferase 3 in myeloid cells worsens hepatic steatosis after a high-fat diet.
    Bourgeois T; Jalil A; Thomas C; Magnani C; Le Guern N; Gautier T; Pais de Barros JP; Bergas V; Choubley H; Mazzeo L; Menegaut L; Josiane Lebrun L; Van Dongen K; Xolin M; Jourdan T; Buch C; Labbé J; Saas P; Lagrost L; Masson D; Grober J
    J Lipid Res; 2021; 62():100013. PubMed ID: 33518513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting Phosphatidylcholine Remodeling in Adipose Tissue Increases Insulin Sensitivity.
    He M; Li Z; Tung VSK; Pan M; Han X; Evgrafov O; Jiang XC
    Diabetes; 2023 Nov; 72(11):1547-1559. PubMed ID: 37625119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential Role of Lysophosphatidylcholine Acyltransferase 3 in the Induction of Macrophage Polarization in PMA-Treated U937 Cells.
    Taniguchi K; Hikiji H; Okinaga T; Hashidate-Yoshida T; Shindou H; Ariyoshi W; Shimizu T; Tominaga K; Nishihara T
    J Cell Biochem; 2015 Dec; 116(12):2840-8. PubMed ID: 25994902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lpcat3 deficiency promotes palmitic acid-induced 3T3-L1 mature adipocyte inflammation through enhanced ROS generation.
    Hu J; Deng Y; Ding T; Dong J; Liang Y; Lou B
    Acta Biochim Biophys Sin (Shanghai); 2022 Nov; 55(1):117-130. PubMed ID: 36331295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of a major liver lysophosphatidylcholine acyltransferase.
    Zhao Y; Chen YQ; Bonacci TM; Bredt DS; Li S; Bensch WR; Moller DE; Kowala M; Konrad RJ; Cao G
    J Biol Chem; 2008 Mar; 283(13):8258-65. PubMed ID: 18195019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate preferences of a lysophosphatidylcholine acyltransferase highlight its role in phospholipid remodeling.
    Kazachkov M; Chen Q; Wang L; Zou J
    Lipids; 2008 Oct; 43(10):895-902. PubMed ID: 18781350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidylcholine acyltransferase 3 knockdown-mediated liver lysophosphatidylcholine accumulation promotes very low density lipoprotein production by enhancing microsomal triglyceride transfer protein expression.
    Li Z; Ding T; Pan X; Li Y; Li R; Sanders PE; Kuo MS; Hussain MM; Cao G; Jiang XC
    J Biol Chem; 2012 Jun; 287(24):20122-31. PubMed ID: 22511767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small Intestine but Not Liver Lysophosphatidylcholine Acyltransferase 3 (Lpcat3) Deficiency Has a Dominant Effect on Plasma Lipid Metabolism.
    Kabir I; Li Z; Bui HH; Kuo MS; Gao G; Jiang XC
    J Biol Chem; 2016 Apr; 291(14):7651-60. PubMed ID: 26828064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver x receptor regulates arachidonic acid distribution and eicosanoid release in human macrophages: a key role for lysophosphatidylcholine acyltransferase 3.
    Ishibashi M; Varin A; Filomenko R; Lopez T; Athias A; Gambert P; Blache D; Thomas C; Gautier T; Lagrost L; Masson D
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1171-9. PubMed ID: 23580142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidylcholine acyltransferase 3 (LPCAT3) mediates palmitate-induced inflammation in macrophages of large yellow croaker (Larimichthys crocea).
    Ding Y; Cui K; Han S; Hao T; Liu Y; Lai W; Xu X; Mai K; Ai Q
    Fish Shellfish Immunol; 2022 Jul; 126():12-20. PubMed ID: 35526799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Hepatic Lysophosphatidylcholine Acyltransferase 3 as a Novel Target Gene Regulated by Peroxisome Proliferator-activated Receptor δ.
    Singh AB; Liu J
    J Biol Chem; 2017 Jan; 292(3):884-897. PubMed ID: 27913621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipid Remodeling in Physiology and Disease.
    Wang B; Tontonoz P
    Annu Rev Physiol; 2019 Feb; 81():165-188. PubMed ID: 30379616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research progress in the role and mechanism of LPCAT3 in metabolic related diseases and cancer.
    Shao G; Qian Y; Lu L; Liu Y; Wu T; Ji G; Xu H
    J Cancer; 2022; 13(8):2430-2439. PubMed ID: 35711841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidylcholine Acyltransferase-3 Expression Is Associated with Atherosclerosis Progression.
    Tanaka H; Zaima N; Sasaki T; Yamamoto N; Inuzuka K; Yata T; Iwaki T; Umemura K; Sano H; Suzuki Y; Urano T; Setou M; Unno N
    J Vasc Res; 2017; 54(4):200-208. PubMed ID: 28683445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane phospholipid remodeling modulates nonalcoholic steatohepatitis progression by regulating mitochondrial homeostasis.
    Tian Y; Jellinek MJ; Mehta K; Seok SM; Kuo SH; Lu W; Shi R; Lee R; Lau GW; Kemper JK; Zhang K; Ford DA; Wang B
    Hepatology; 2024 Apr; 79(4):882-897. PubMed ID: 36999536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structural basis for the phospholipid remodeling by lysophosphatidylcholine acyltransferase 3.
    Zhang Q; Yao D; Rao B; Jian L; Chen Y; Hu K; Xia Y; Li S; Shen Y; Qin A; Zhao J; Zhou L; Lei M; Jiang XC; Cao Y
    Nat Commun; 2021 Nov; 12(1):6869. PubMed ID: 34824256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.